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Mammary gland development initiates postnatally with the development of terminal end buds (TEBs) at the end of the
rudimentary ducts. These grow out through the fat pad and bifurcate to lay down the rudimentary ductal tree. At the
initiation of their development, TEBs recruit to their surrounding stroma a substantial population of macrophages. Using
mice homozygous for a null mutation in the gene for the macrophage growth factor, colony stimulating factor-1 (CSF-1),
that are severely depleted in macrophages, we demonstrated that CSF-1-regulated macrophages are required for normal
branching morphogenesis in the mammary gland. However, these mice have a pleiotropic phenotype as a result of the
generalized macrophage deficiency. To test that the effect of the mutation observed in the mammary gland was
organ-autonomous, we developed a tetracycline-binary system whereby CSF-1 was specifically expressed in the mammary
epithelium under the regulation of the MMTV-promoter. This restored mammary macrophage populations but not those in
other tissues and corrected the branching morphogenesis defect. Inhibition of CSF-1 expression by tetracycline treatment
for varying periods suggested that CSF-1-regulated macrophages are required throughout early mammary gland develop-
ment. These data show that macrophages acting locally are required for branching morphogenesis of the mammary
gland. © 2002 Elsevier Science (USA)
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The mammary gland is a unique organ in that its major
development occurs postnatally. A newly born female pup
has a rudimentary mammary structure with a small ductal
tree composed of epithelial cells embedded in a fat pad. At
about 3 weeks of age, terminal end buds (TEBs) appear at the
end of most ducts. These end buds have a club-shaped
structure with multiple layers of epithelial cells (Bresciani,
1968). The inner epithelial cells are largely composed of
body cells, which differentiate into the luminal, or ductal
epithelial cells, while the outermost cells, known as cap
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All rights reserved.cells, differentiate into the myoepithelial cells (Williams
and Daniel, 1983). Rapidly dividing cells at the end of the
TEB elongate the duct into the fat pad that together with
regular bifurcation gives rise to the ductal tree. With the
onset of ovary maturation around 4–6 weeks of age, the
ducts continue to grow until they reach the end of the fat
pads, at which point TEBs disappear to be replaced by
terminal end ducts (Daniel and Silberstein, 1987). A hall-
mark of the adult virgin gland is the maintenance of ductal
spacing with the major branches equally spaced in the fat
pad.
The primary regulation of prepubertal mammary gland
development is estrogen derived from the ovary. However,
there is considerable evidence for local mesenchymal–
epithelial interactions during this development that in-
volves the local synthesis of growth factors such as HGF,
TGF, and FGF (Pollard, 2001). In fact, the importance of
the mammary fat pad in specifying mammary epithelial
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identity has long been recognized (Haslam, 1991). Recently,
we have shown that the cellular composition of the fat pad
changes during development by the recruitment of migra-
tory cells of the hematopoietic system, specifically macro-
phages and eosinophils, to the stroma surrounding the TEB
as they form and grow. In mouse mutants that restrict the
recruitment of these cells, the ductal tree is less complex,
suggesting an important role for these cells in the local
epithelial–mesenchymal interactions (Gouon-Evans et al.,
2000).
These results implicating macrophages in the outgrowth of
the mammary gland were, at least in part, derived from
studies with mice homozygous for a null mutation (Csf1op) in
the macrophage growth factor, colony stimulating factor-1
(CSF-1), gene (Pollard and Stanley, 1996; Wiktor-Jedrzejczak et
al., 1991; Yoshida et al., 1990). CSF-1 regulates mononuclear
phagocyte and macrophage growth, viability, and differentia-
tion, as well as being a major chemoattractive factor for these
cells (Stanley, 1990; Tushinski et al., 1982; Webb et al., 1996).
Thus, homozygous CSF-1 null mutants have a paucity of
macrophages in many tissues, including the mammary gland
(Gouon-Evans et al., 2000; Pollard and Stanley, 1996). Analy-
sis of mammary gland development in these mice showed a
structure with fewer TEBs, a lower rate of outgrowth across
the fat pad, and fewer branches during its development.
Consequently, the mature gland is an atrophic, poorly
branched structure (Gouon-Evans et al., 2000). Furthermore,
there was a relative failure of branching morphogenesis during
pregnancy (Pollard and Hennighausen, 1994). A similar phe-
notype to the CSF-1 ligand null mutant mouse has recently
been reported for mice homozygous for an inactivating muta-
tion in the CSF-1 receptor gene (Dai et al., 2002).
These data provide strong evidence for CSF-1/CSF-1R
signaling in mammary gland-branching morphogenesis, a
role that is effected through macrophages. However, the
absence of macrophages in other tissues of the CSF-1 or
CSF-1R null mutant mice also has other phenotypic conse-
quences that include a delay in ovary maturation and an
aberrant sex steroid hormone feedback regulation in the
hypothalamus (Cohen et al., 1997a,b; Dai et al., 2002).
Although the mammary gland defect in Csf1op/Csf1op mice
is unlikely to be due to endocrine defects since the mam-
mary gland phenotype was still evident in ovariectomized
Csf1op/Csf1op mice reconstituted with physiological con-
centrations of estrogen, it is impossible to completely rule
out the possibility that the mammary gland defect of the
Csf1op/Csf1op mice could be due entirely or in part to
systemic influences rather than the local absence of mac-
rophages in the mammary gland. To distinguish between
these possibilities, we have used a tetracycline-regulated
system (Gossen and Bujard, 1992; Kistner et al., 1996) to
control the temporal and spatial expression of a CSF-1
transgene specifically in the mammary epithelial cells of
the Csf1op/Csf1op mice. These results show that the devel-
opment of the mammary gland is locally regulated by CSF-1
through the action of macrophages.
MATERIALS AND METHODS
Animals, Mammary Gland Transplantation,
and Histology
Osteopetrotic Csf1op/Csf1op mice and littermate controls
/Csf1op (defined as wild type mice; Ryan et al., 2001) were bred
and maintained in an isolated unit at the Albert Einstein College of
Medicine animal house as described previously (Pollard et al.,
1991). Mice were fed powdered chow and infant milk formula
(Enfamil) ad libitum. At 10 days of age, Csf1op/Csf1op were distin-
guished from /Csf1op mice by the absence of incisors. Transgenic
mice were maintained under the same barrier conditions. MMTV-
tTA mice (Hennighausen et al., 1995) were a kind gift from Dr.
Lothar Hennighausen (Laboratory of Genetics and Physiology and
the National Institute of Diabetes, Digestive and Kidney Diseases,
National Institutes of Health).
Transplantation of mammary tissue was performed by placing
approximately 1-mm2 pieces of adult mammary glands from
Csf1op/Csf1op and /Csf1op mice into cleared fat pads of 3-week-old
C3H RAG2/ severe combined immunodeficient mice (SCID)
(Shinkai et al., 1992) following the procedure of DeOme et al.
(1958). The grafts were allowed to grow out into the mammary
gland for 4–6 weeks before whole-mount preparations were made.
For mammary whole mounts, the fourth inguinal mammary glands
were removed and flattened on glass slides followed by fixation
overnight in 75% ethanol and 25% acetic acid. After washing, they
were stained in alum carmine (1 g of Carmine Dye, 2.5 g Potassium
Alum, and a few thymol crystals in 500 ml of distilled water) before
being defatted in toluene. Photographic images of the whole
mounts were scanned into the computer by using the NIH Image
software. This program was used to measure the total length of the
ductal tree, and the resultant data were normalized to the size of
the cleared fat pad. Branching number was measured as previously
described (Gouon-Evans et al., 2000). Afterward, the mammary
glands were processed for histology.
For immunohistochemical staining, mammary glands were fixed
overnight in 10% neutral buffered formalin. Tissues were dehy-
drated through graded alcohols, embedded in paraffin, and sec-
tioned at 5 m. For anti-F4/80 antibody staining, rat monoclonal
cell supernatant was used as described (Austyn and Gordon, 1981;
Cecchini et al., 1994). Detection of anti-F4/80 binding was per-
formed by using an avidin-biotin/peroxidase kit (Vector Laborato-
ries Inc., Burlington, CA) as described by the manufacturer’s
protocol. A similar procedure was used for anti-Mac3 antibody
(PharMingen International, San Diego, CA).
Construction of Tetracycline Operator-CSF-1
cDNA Transgene
The CSF-1 cDNA containing exon 10 (Ladner et al., 1988) was
cloned downstream of a minimally active cytomegalovirus (CMV)
promoter controlled by seven tetracycline operator sequences. The
3.8-kDa CSF-1 cDNA was removed from the plasmid pGEM3-M-
CSF-10 by EcoRI digestion. The EcoRI fragment was cloned into
pGEM7 at the multiple cloning site. The complete cDNA contain-
ing exon 10 was cloned into plasmid 609 between the tetracycline
operator and a SV-40 polyadenylation signal sequence (a kind gift
from Dr. Lothar Hennighausen) in two steps. First, a 2.2-kb
XbaI–BamHI fragment was ligated into 609 plasmid followed by a
1.6-kb BamHI fragment yielding a complete 609/2.2/1.6 plasmid,
named 10/609 (abbreviated tg). For transgene injection, a 5-kb
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FIG. 1. CSF-1 is detected in the salivary and mammary glands of CSF-1-inducible transgenic Csf1op/Csf1op mice. (A) CSF-1 was measured
by RIA in tissues shown on the x-axis in double-transgenic (dark histograms) and single (light histograms)-transgenic Csf1op/Csf1op mice or
in the serum of mice with the genotypes indicated on the x-axis. (B) CSF-1 concentrations in the mammary glands of the single- and
double-transgenic Csf1op/Csf1op and wild type mice. CSF-1 concentrations were significantly higher in the double-transgenic Csf1op/Csf1op
mice compared with wild type or the single Csf1op/Csf1op mice (P 0.001, Student’s t test). (C) Expression of CSF-1 transcripts was detected
in the double-transgenic Csf1op/Csf1op by RT-PCR. Control template 10/609 yielded a 320-bp band (lane 13). RNA isolated from MMTV-tTA
Csf1op/Csf1op mammary gland (lanes 1) and MMTV-tTA /Csf1op (lane 6), from tetop-CSF-1 Csf1op/Csf1op mammary gland (lanes 2 and 4)
and from MMTV-tTA and tetop-CSF-1 Csf1op/Csf1op mammary gland (lanes 3 and 5) were first reverse-transcribed and amplified by using
primers specific for the 10/609 transgene. Lanes 7–12 were the same as lanes 1–6, except the RNA was not reverse-transcribed. No band
was detected in sample without template DNA (lane 14). Amplification of the actin transcript (250 bp) was used as a control for the amount
of input RNA in the reaction and was detected in lanes 1–6. (D) Expression of CSF-1 transcripts was downregulated in double-transgenic
Csf1op/Csf1op mice treated with doxycycline. All RNA used for reverse transcription was isolated from 6-week-old mammary glands. The
cDNA was amplified for the CSF-1 transcripts by PCR for 25 cycles (lanes 1–7) and for 35 cycles (lanes 8–14). Lanes 1, 2, 8, and 9 contained
RNA from individual untreated double-transgenic Csf1op/Csf1op; lanes 3, 4, 10, and 11 were from double-transgenic Csf1op/Csf1op mice
treated for 3 weeks (lane 3,10) and 6 weeks (lane 4,11) with doxycycline. Lanes 5 and 12, Csf1op/Csf1op; lanes 6 and 13; wild type mammary
gland; lanes 7 and 14, negative controls, no template cDNA was added to the PCR reaction. The actin transcript (250 bp) indicated an equal
input of RNA.
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fragment was excised from 10/609 digestion with AatII and BglII
digestion. All constructs were confirmed by restriction endonucle-
ase digestion and sequencing.
Transient Transfection Assay for Secreted CSF-1
Approximately 1  105 cells of a transfectable Chinese hamster
ovary (CHO) cell line, LR-73 (Pollard and Stanners, 1979), were
plated onto a 100-mm plate containing 10 ml of MEM 10% fetal
bovine serum (FBS) (v/v) at 37°C and cultured overnight. The
plasmid pRC/RSV-tTA (tTa) with a constitutively active RSV
promoter (a kind gift from Dr. Glenn I. Fishman, Mount Sinai
School of Medicine, New York, NY) and 10/609 were cotransfected
into these cells by using poly-L-ornithine (Dong et al., 1993). After
transfection, the cells were incubated at 37°C for 3 days followed
by collection of the culture medium. This was assayed for CSF-1
secretion by radioimmunoassay (RIA) (Bartocci et al., 1986; Guil-
bert et al., 1986).
In the tetracycline repression experiment, 5 105 cells that have
been transfected with pRC/RSV-tTA and with 10/609 were laid
down and allowed to grow in 10 ml of MEM and 10% FCS
overnight at 37°C. The next day, the medium was replaced with 5
ml of fresh medium containing the tetracycline analog, doxycy-
cline. The cells were allowed to grow for an additional 3 days, at
which time the cultured medium was collected for measurement of
CSF-1 concentration by RIA.
Construction of Transgenic Mice and Screening for
Founders
The purified cDNA inserts from 10/609 were used for microinjec-
tion of fertilized mouse oocytes by using conventional methods.
Founders were screened for DNA integration by PCR analysis of tail
DNA and transgene-positive mice bred. Tail DNA was also used to
screen for mice carrying the transactivator (tTA). The PCR primers
used at 0.25 M were: for 10/609, JWP 138, 5-ATA GAA GAC ACC
GGG ACC GAT CC-3 located in the CMV promoter; JP52, 5-GCG
TAC CAG AGT AGA TAA TA-3 in exon 4 of CSF-1 cDNA; for
MMTV-tTA, JWP 213, 5-CTG ATC TGA GCT CTG AGT G-3 in
MMTV-LTR; and JWP 214b, 5-TAT CTA ACA TCT CAA TGG CTA
AGG C-3 in the tetR region (Hennighausen et al., 1995). In each case,
the mixture was amplified under the following conditions: 1 cycle at
94°C for 5 min, 35 cycles of 94°C for 1 min, 50°C for 2 min, and 74°C
for 2 min, and one cycle at 74°C for 5 min. The amplified PCR
products were separated on a 1.6% agarose gel. A 280-bp band
indicated the transactivator (tTA) and 600-bp 10/609 transgenes.
These results were confirmed by Southern blotting of tail DNA.
Genotyping Osteopetrotic (Csf1op/Csf1op) Mice
Using Fluorescent-Tagged Primers
PCR primers were designed to span the thymidine insertion muta-
tion in exon 4 of the CSF-1 gene as described (Pollard et al., 1991; Ryan
FIG. 2. Macrophages were recruited to the double-transgenic Csf1op/Csf1op mammary gland. Sagittal sections of mammary glands
immunostained using the mononuclear phagocytic anti-F4/80-specific antibody and counterstained with hematoxylin. Area selected to
show TEB and the brown deposit indicates F4/80 cells. (A) tetop-CSF-1 Csf1op/Csf1op. (B–D) MMTV-tTA, tetop-CSF-1 double-transgenic
mammary glands. (B) Untreated. (C, D) Double-transgenic Csf1op/Csf1op mice treated with doxycycline for 3 weeks (C) or 6 weeks (D).
Original magnification, 100.
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et al., 2001). The region containing the Csf1op allele was amplified by
using PCR, and the one-base thymidine insertion was detected by
using a sequencing gel. One microliter of tail DNA was added to the
24-l master mix containing 500 M dNTPs, 2.25 mM MgCl2, 200 ng
of primer 6-Fam Int3F, FAM-5-CCT AGG GTG TGA TCG TCT
CAT ATA AAG CC TG-3 in the third intron of the CSF gene; and
200 ng of primer JP 52, 5-CGC ATG GTC TCA TCT ATT AT-3 in
the fourth exon and 1.25 unit of Pyrococcus woesei (PWO) enzyme
mix to each tube. The reaction was amplified under the following
conditions: 1 cycle at 92°C for 20 s, 35 cycles of 92°C for 20 s, 58°C for
1 min, and 68°C for 1 min, and one cycle at 68°C for 5 min. The
154-bp fluorescent PCR product was detected on the sequencing gel
run on a PE Applied Biosystems 377 DNA Sequencers (Foster City,
CA) for the wild type allele and 155-bp product for the mutant allele.
Detection of 10/609 Transgene Expression in the
Mammary Gland by RT-PCR
RNA was prepared from the fourth inguinal mammary gland by
using the guanidinium isothiocyanate procedure (GTC) (Chomczyn-
ski and Sacci, 1987). RNA (2.5g) was reverse transcribed by using the
Superscript II Kit (Life Technology, Gibco/BRL, Rockville, MD) ac-
cording to the manufacturer’s suggested protocol. Two microliters of
this cDNA was amplified in a 50-l reaction mixture containing 10
mM of MgCl2, 2 mM of dNTP, 250 M of exon 10 EL primer, 5-GGG
TGC CTG GTT ACA TCG GAG CAG GGG-3, 250 M of 609RV1
primer, 5-GGG TCC CCA AAC TCA CCC TG-3, and 0.625 U of
Taq Polymerase. The PCR was amplified under the following condi-
tions: 1 cycle at 94°C for 5 min, 35 cycles of 92°C for 30 s, 55°C for
30 s, and 72°C for 1 min, and one cycle at 72°C for 5 min. A 320-bp
amplified product was detected in 1% agarose gel.
RIA for Detection of CSF-1 Protein
Tissue samples were weighed, a 10 volume of ice-cold RIA
buffer (-MEM containing 25 mM Hepes, 0.2% BSA, and 0.02%
sodium azide, pH 7.3) added, and the tissues homogenized, heated
at 56°C as described (Bartocci et al., 1986). RIA was performed by
using the one-step overnight procedure at room temperature (Bar-
tocci et al., 1986; Guilbert et al., 1986).
FIG. 3. Restoration of CSF-1 in the mammary gland enhances ductal development. Whole-mount mammary glands were prepared from
single transgenic Csf1op/Csf1op mice (A, D, and G), double-transgenic Csf1op/Csf1op mice (B, E, and H), and /Csf1op mice (C, F, and I). The
mammary glands were harvested at 5 (A–C), 6 (D–F), and 8 weeks (G–I). Arrowheads point to the TEBs. Magnification, 10.
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Tetracycline Implants or Doxycycline Treatment
To address the effectiveness of tetracycline in repressing CSF-1
secretion in the transgenic mice, osteopetrotic mice carrying the
transgenes were screened for the expression of CSF-1 in various
tissues by RIA. Founders containing the CSF-1 transgene and
MMTV-tTA that expressed CSF-1 highly in the salivary glands
were selected. Twenty-one-day tetracycline release pellets (releas-
ing 0.7 mg tetracycline hydrochloride per day) were obtained from
Innovative Research of America (Toledo, OH) and implanted sub-
cutaneously in the shoulder region of the mice according to
manufacturer’s directions. The pellet was kept in place for 7 days
(Furth et al., 1994) before the tissues were harvested and processed
for CSF-1 RIA. For experiments on mammary gland development,
dams that recently gave birth were treated with doxycycline in
water (1 mg/ml) (Kistner et al., 1996). These pups were treated with
doxycycline again, once they were weaned from their mothers until
they were 6 weeks of age. Another set of mice were given
doxycycline in water (1 mg/ml) starting at 3 weeks of age following
weaning from their mothers. In both cases, the pups were given
powder chow supplemented with 20 ml of milk containing 1
mg/ml of doxycycline daily. At the end of the experiment, the
fourth inguinal mammary glands were processed for whole-mount
analysis or for the isolation of RNA as described above.
RESULTS
Regulated Expression of Colony Stimulating
Factor-1 (CSF-1) in Vitro and in Vivo
To address whether the function of the stroma of osteo-
petrotic mice can be rescued by local production of CSF-1 in
the mammary gland, we expressed CSF-1 in the mammary
gland of the mutant mice in a regulated way by using a
tetracycline binary system where the tetracycline-
transactivator was regulated by the mammary epithelium-
restricted MMTV promoter. Initially, the tetracycline sys-
tem was tested in vitro to ensure that the CSF-1 target gene
was functional and repressible. The construct 10/609 car-
rying the CSF-1 cDNA ligated downstream of the CMV
promoter regulated by seven operator regions was cotrans-
fected into LR-73 Chinese hamster cells with a plasmid that
had the tTA under the control of the constitutively active
RSV promoter. The culture medium from the transfected
cells was collected and CSF-1 concentration in the medium
was determined by RIA that measures mouse but not
hamster CSF-1 (Bartocci et al., 1986; Guilbert and Stanley,
1986). Culture media from cells transfected with either
10/609 or the pRC/RSV-tTA transactivator alone had no
CSF-1. However, when both constructs were cotransfected
into the cells, over 11 ng/ml of CSF-1 was detected in the
cultured media. To test whether the production of CSF-1
was regulated by tetracycline, cells that had been trans-
fected with pRC-RSV-tTA and 10/609 were incubated with
various concentrations of doxycycline, a tetracycline de-
rivative. The expression of CSF-1 was completely repressed
by doxycycline at concentrations above 40 ng/ml (data not
shown).
These tissue culture experiments gave confidence that
the CSF-1 construct was regulated by the tetracycline
transactivator. Consequently, it was used to generate trans-
genic mice. Five different founder transgenic mouse lines
carrying the tetop-CSF-1 cDNA containing exon 10 were
mated to Csf1op/Csf1op male mice. Mice carrying the tetop-
CSF-1 (10/609) transgene and Csf1op allele were then
crossed with mice expressing tTA from the MMTV-
promoter and all genotypes generated. As a preliminary to
studying the effects of CSF-1 on mammary gland develop-
ment, a range of tissues from Csf1op/Csf1op mice carrying
both transgenes were harvested and CSF-1 was measured by
using the CSF-1 RIA. Csf1op/Csf1op mice with the complete
tet-transgene system expressed CSF-1 in the salivary gland.
Over 770 pg/mg tissue of CSF-1 was detected in the salivary
gland of the Csf1op/Csf1op carrying both transgenes, but
none was detected in mice carrying either of the transgenes
singly (Fig. 1A). CSF-1 was not detected in other tissues
(assay sensitivity 1 pmol), although there was a slight
amount of CSF-1 in the tongue, but this could be derived
from salivary gland secretion (Fig. 1A). This is consistent
with the reported activity of the MMTV promoter, which is
expressed in the salivary as well as the mammary gland
(Ewald et al., 1996). Importantly, no CSF-1 was detected in
FIG. 4. Mammary gland ductal development was improved by
CSF-1 expression specifically in Csf1op/Csf1op mammary glands.
Ductal length and number of branches were measured as described
in Materials and Methods in single (open histograms)- or double
(hatched histograms)-transgenic Csf1op/Csf1op mammary glands.
Mammary glands were isolated at 5, 6, and 8 weeks of age. P values
are indicated above the pairs of histograms comparing Csf1op/Csf1op
mice containing a single transgene with those expressing the two
transgenes. NS; not significant.
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the serum of these double transgenic Csf1op/Csf1op mice
(Fig. 1A). In contrast, CSF-1 was detected in most tissues
and the serum (Fig. 1A) of wild-type nontransgenic mice
(Bartocci et al., 1986).
In order to determine whether CSF-1 was expressed in the
mammary gland, homogenates of mammary tissue of 11- to
15-week-old mice were used to measure CSF-1 concentra-
tion. In Csf1op/Csf1op mice carrying the single tTA-
transgene, CSF-1 was not detected, with the value being
similar to that found in a blank tube. However, in mice
bearing both transgenes, the homogenates contained 20
pg CSF-1/mg of tissue (Fig. 1B). In contrast, CSF-1 could also
not be detected in the mammary glands of /Csf1op mice
(Fig. 1B). This is despite the presence of CSF-1 mRNA
(Gouon-Evans et al., 2000) and the identification of the
mammary epithelium as expressing CSF-1 mRNA using a
reporter system (Ryan et al., 2001). The most probable
explanation for this inability to detect CSF-1 is that the
epithelial compartment represents only 5% of the whole
mammary gland and therefore the dilution effect of the
remaining non-CSF-1-expressing tissue was very large. Fur-
thermore, the large amount of fat compromises the CSF-1
assay and makes it less sensitive than assays in other less
fatty tissues. Despite these caveats, these data show that
the tetracycline binary system leads to expression of CSF-1
to greater levels than physiologically observed.
Expression of CSF-1 was confirmed by RT-PCR of RNA
extracted from the double transgenic mammary glands
using primers that span an intron of the CSF-1 gene.
Positive results showed a band at 320 bp comparable to that
found using 10/609 DNA as a template (Fig. 1C, lane 13).
No CSF-1 transcripts were detected in total mammary
gland RNA isolated from Csf1op/Csf1op mice carrying
MMTV-tTA transgene (Fig. 1C, lanes 1 and 6), although a
low level of mRNA expression was detected in RNA
isolated from Csf1op/Csf1op mice carrying the tetop-CSF-1
(Fig. 1C, lanes 2 and 4). However, substantially increased
expression was detected in mammary gland RNA isolated
from Csf1op/Csf1op mice carrying both the transgenes (Fig.
1C, lanes 3 and 5). Amplification of control actin RNA (250
bp) indicated that an equal amount of RNA was present in
each sample during the amplification (Fig. 1C, lanes 1–6,
lower band). There were no products amplified from RNA
isolated from the wild type mammary gland with MMTV-
tTA transgene but lacking the CSF-1 transgene (Fig. 1C,
lane 6) or from RNA that was not reverse transcribed (Fig.
1C, lanes 7–12) nor from which the cDNA template was not
added (Fig. 1C, lane 14). These data show that there is a very
low level of CSF-1 expression in mice harboring a tetop-
CSF-1 cDNA and that this is substantially increased in the
presence of tTA driven from the MMTV promoter.
Another cohort of mice were treated with doxycycline
from birth, and the effect of this treatment on CSF-1
expression was determined by RT-PCR of RNA extracted
from the mammary gland. In double transgenic mice killed
at 6 weeks of age, transcripts were detected in mammary
gland RNA as discussed above after 25 cycles of amplifica-
tion, while these were absent in the mammary gland
samples when doxycycline was given from 3 weeks of life
for 3 weeks or for the first 6 weeks of life (Fig. 1D).
However, after 35 cycles, transcripts were detected in the
sample from mice treated for 3 weeks but not in those
treated for 6 weeks (Fig. 1D). Amplification of the actin
signal was similar in all samples according to cycle of
amplification, indicating similar amounts of input RNA.
Thus, doxycycline treatment suppressed CSF-1 transcrip-
tion effectively but not completely in vivo.
Locally Synthesized CSF-1 Recruits Macrophages
into the Mammary Gland
To determine whether macrophages are recruited into the
mammary glands of CSF-1-expressing transgenic mice, we
performed immunohistochemical staining using the mono-
nuclear phagocyte-restricted anti-F4/80 and anti-Mac-3 an-
tibodies. It has been shown that the F4/80 antigen is
abundantly expressed in macrophages but also to a lesser
degree in eosinophils (Gouon-Evans et al., 2000; McGarry
and Stewart, 1991). However, these two cells can be differ-
entiated by morphological criteria, in that eosinophils are
rounder polymorphonuclear cells, whereas macrophages are
mononuclear with numerous extensions and hence ap-
peared much flatter with a single nucleus (Gouon-Evans et
al., 2000; Hume et al., 1984). Numerous F4/80-positive
cells were detected with an anti-F4/80 antibody in the
stromal compartment in the “neck” region of the TEBs of
Csf1op/Csf1op mice carrying tetop-CSF-1 and MMTV-tTA
transgenes (Fig. 2B) when compared with the relative lack of
these cells in Csf1op/Csf1op mice carrying only the tetop-
CSF-1 transgene (Fig. 2A). In fact, as reported before
(Gouon-Evans et al., 2000) most of the F4/80-positive cells
found around the TEB of the Csf1op /Csf1op mammary gland
were polymorphonuclear and spherical, consistent with
them being eosinophils (Fig. 2A). In contrast, the majority
of the F4/80-positive cells in the double-transgenic Csf1op
/Csf1op mammary glands expressing CSF-1 had the flat,
mononuclear morphology typical of macrophages (Fig. 2B).
In the double-transgenic mice, F4/80-positive cells were
also observed within the TEB and in the surrounding
stromal compartment (Fig. 2B). Immunohistochemical
staining with anti-Mac-3 antibody confirmed that cells
around TEBs were macrophages (data not shown). These
data provide evidence that the tetracycline binary system
directs expression of CSF-1 to the mammary gland of the
Csf1op/Csf1op mice and that this recruits macrophages into
the mammary gland. We also examined F4/80-positive cells
in the liver of these double-transgenic mice but found no
correction of this CSF-1-sensitive population (data not
shown).
Anti-F4/80 immunohistochemical staining was used to
assess the effect of doxycycline treatment on the population
of macrophages around the TEBs in the double-transgenic
Csf1op/Csf1op mammary glands. There was a reduction of
F4/80-positive cells in double-transgenic Csf1op/Csf1op
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mammary gland treated with doxycycline for 6 weeks, but
they were not depleted to the extent found in Csf1op/Csf1op
mice (Figs. 2A and 2D). These cells were mostly round and
mononuclear. This contrasted with the double-transgenic
Csf1op/Csf1op mammary gland that had been treated with
doxycycline from 3 weeks of age for 3 weeks in which a
mixture of both round and flat F4/80-positive cells were
observed around the TEBs (Fig. 2C). In summary, double-
transgenic mammary glands that have been treated with
doxycycline have a reduced number of macrophages sur-
rounding the TEB and this reduction is proportional to the
length of treatment. This is consistent with the require-
ment of CSF-1 for macrophages viability (Tushinski et al.,
1982) and with CSF-1 being a chemoattractant for these
cells (Webb et al., 1996). These data also support our
hypothesis that local production of CSF-1 is required in the
mammary gland for macrophages recruitment during devel-
opment.
Ductal Outgrowth Is Partially Rescued by Local
Expression of CSF-1
The mammary glands of Csf1op/Csf1op mice during devel-
opment display fewer TEBs, less ductal branching, and
shorter ductal length than those of wild type mice (Gouon-
Evans et al., 2000). Consequently, the adult glands, al-
though eventually developing to cover the entire fat pad, are
atropic with fewer branches compared with wild type mice.
To analyze the local and temporal requirement for CSF-1,
the tetracycline-binary system under the control of the
MMTV-promoter was used to control CSF-1 expression
within the mammary gland during the first 6 weeks of life.
FIG. 5. Doxycycline treatment suppresses ductal outgrowth in double-transgenic Csf1op/Csf1op mammary gland. Whole-mount mammary
glands at 6 weeks of age. (A) Csf1op/Csf1op. (B–D) Double-transgenic Csf1op/Csf1op mice treated with doxycycline for 6 weeks (B), 3 weeks
(D), or untreated (C). /Csf1op mice untreated (E) or treated with doxycycline for 6 weeks (F). Magnification, 10.
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Measurements of mammary development were performed
by counting the numbers of branches as well as measuring
ductal length as described in Materials and Methods.
The development of the Csf1op/Csf1op mammary gland
(Fig. 3A) was very retarded compared to the already well-
developed structure of the wild type mammary glands at 5
weeks (Fig. 3C) as has been previously described (Gouon-
Evans et al., 2000). The wild type gland displayed many
TEBs and a ductal structure that had already progressed
beyond the lymph node, whereas the mutant had barely
begun to develop. In the double-transgenic Csf1op/Csf1op
mammary gland, the ductal system was much more ad-
vanced and elaborate compared with the single transgenic
Csf1op/Csf1op mammary gland at this age (Figs. 3A and 3B)
with more branches and increased ductal length (Figs. 4A
and 4B). In fact, the ductal structure had already progressed
to the lymph node, a landmark that was not achieved in the
Csf1op/Csf1op mice until 6 weeks of age (Fig. 3D). By 6 weeks
of age, the double-transgenic Csf1op/Csf1op mammary gland
had numerous ducts progressing beyond the lymph node
and formed a coherent fan-shaped structure. In contrast, the
single transgenic Csf1op/Csf1op mammary gland had few
ducts and these had only just reached the lymph node and
were randomly distributed (Figs. 3D and 3E). Total ductal
length and number of branches were significantly higher in
the double-transgenic Csf1op/Csf1op mammary glands com-
pared with those with one transgene at this age (Figs. 4A
and 4B).
By 8 weeks of age, the wild type mammary glands were
mature with ducts that had reached the end of the fat pad
concurrent with the disappearance of TEBs (Fig. 3I). How-
ever, at this age, the double-transgenic Csf1op/Csf1op mam-
mary gland still showed some TEBs, although the ductal
structure had almost reached the end of the fat pad (Fig. 3H).
Although the ductal length was significantly higher in the
double-transgenic mammary gland compared with the
single transgenic gland at 8 weeks, the number of branched
was now not significantly different (Fig. 4B). Nevertheless,
the overall development of the mammary gland from mice
with two transgenes was much advanced compared with
the mutant gland from mice with a single transgene at 8
weeks (Figs. 3G and 3H). In summary, ductal development
was accelerated in Csf1op/Csf1op mice by expression of
CSF-1 within the mammary gland but not to a rate that was
equivalent to that observed in wild type mice.
In order to examine the temporal requirement for CSF-1
in the mammary glands, double-transgenic Csf1op/Csf1op
mice were treated with doxycycline to inhibit CSF-1 ex-
pression for either the first 6 weeks of life or for 3 weeks
following weaning at 21 days. Whole-mount preparations of
mammary glands from double-transgenic Csf1op/Csf1op
mice treated for the first 6 weeks of life with doxycycline
had poorly developed ductal system when compared with
the untreated double-transgenic controls (Figs. 5B, 5C, and
6) and comparable to the Csf1op /Csf1op mammary gland
development without the transgene (Figs. 5A, 5B, and 6).
When doxycycline was given from 3 weeks of age, the
ductal system in the double-transgenic Csf1op/Csf1op mam-
mary gland was still significantly less developed at 6 weeks
of age compared with the double-transgenic Csf1op/Csf1op
mammary gland without doxycycline treatment (Figs. 5C
and 5D). However, the effect on ductal outgrowth was not
as severe as that seen in the double-transgenic Csf1op/Csf1op
mammary gland maintained on doxycycline for the full
6-week period (Figs. 5B and 5D). Treatment of doxycycline
in drinking water over the 6-week period had no effect on
ductal outgrowth of the wild type mammary gland (Figs. 5E,
5F, and 6). Quantitatively, there was a significant decline in
ductal outgrowth in the double-transgenic Csf1op/Csf1op
mammary gland following doxycycline treatment, whether
it was started at birth (P  0.0001) or at 3 weeks of age (P 
0.019) (Fig. 6). Six weeks of treatment had a much greater
effect than three weeks of treatment. A significant (P 
0.001) decrease in the number of branches was observed
between double-transgenic Csf1op/Csf1op mammary gland
treated with doxycycline from birth compared with un-
treated controls. However, this was not observed in double-
transgenic Csf1op/Csf1op mammary gland treated with doxy-
FIG. 6. Suppression of CSF-1 expression by doxycycline affects
mammary gland development in double-transgenic Csf1op/Csf1op
mice. Ductal length and number of branches were measured in
mammary glands from 6-week-old mice of genotype Csf1op/Csf1op
(columns 1–4) or/Csf1op (columns 5 and 6) indicated on the x-axis
that had been treated for 3 weeks (column 3), 6 weeks (columns 4
and 5), or not (columns 1, 2, and 6) with doxycycline. Comparisons
indicating statistical differences are shown as P values above the
histograms. NS, not significant.
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cycline from 3 weeks (Fig. 6). In summary, doxycycline
treatment suppressed the ductal outgrowth and the number
of branches in the double-transgenic Csf1op/Csf1op mam-
mary gland and the requirement for CSF-1 appears continu-
ous through the first 6 weeks of life.
Wild Type Mammary Stroma Rescues the Defects
in Epithelial Outgrowth Observed
in Csf1op/Csf1op Mice
In order to determine whether the hypoplastic mammary
glands of Csf1op/Csf1op mice is due to a defect in the
mammary epithelial cells or in the stromal compartment,
fragments of mutant and wild type mammary tissues were
transplanted into the cleared but functional fat pads of
immunodeficient Rag2/ mice (SCID) and their outgrowth
was measured. Thirty-six virgin SCID mice at 3 weeks of
age were recipients for the mammary fragments. These
were allowed to grow for 4–6 weeks before being harvested.
No significant differences were observed in the number of
outgrowths from /Csf1op or Csf1op/Csf1op transplants at 5
weeks (10 of 11 /Csf1op and 9 of 11 Csf1op/Csf1op) or 6
weeks (8 of 10 /Csf1op and 7 of 10 Csf1op/Csf1op) after
transplantation. The Csf1op/Csf1op mammary gland trans-
plants grew into the cleared fat pads of Rag2/ mice in a
similar fashion to the /Csf1op tissues at either 4 (Figs. 7A
and 7B), 5 (Figs. 7C and 7D), or 6 weeks (Figs. 7E and 7F)
after transplantation. No ductal outgrowth was observed in
six of the cleared fat pads that did not receive mammary
grafts (Fig. 7H). To measure the extent of mammary epithe-
lial outgrowth in the cleared fat pad, photomicrographs of
the whole-mount mammary glands were scanned and the
total ductal length was measured by using the NIH Image
software as described above (Fig. 7G). Quantitatively, there
were no significant differences in the outgrowth of either
Csf1op/Csf1op or /Csf1op grafts into the recipient mam-
mary stroma (Fig. 7I). These data suggest that the defect
seen in ductal development in the Csf1op/Csf1op mice is in
the stromal compartment and not in the mutant epithelial
cells per se. This is consistent with the rescue of macro-
phages in the stroma by expression of CSF-1 in the mam-
mary epithelium.
DISCUSSION
The central growing points of the mammary epithelium
are the TEBs. These highly proliferative, multilaminate
structures grow out and migrate through the fat pad. In this
process, they recruit around themselves a unique stroma
that tends to isolate the growing epithelial cells from the
adipocytes that constitute the major portion of the fat pad
across which the ductal structures grow. This stroma con-
sists of fibroblasts and, interestingly, cells of the hemato-
poietic system, particularly macrophages and eosinophils.
Recently, by using mouse mutants in growth factors/
chemokines that result in the reduction of the density of
macrophages and eosinophils, these hematopoietic cells
were shown to have an important influence on the branch-
ing morphogenesis of the mammary epithelium. This effect
was particularly pronounced following macrophage deple-
tion (Gouon-Evans et al., 2000).
The major regulator of cells of the mononuclear phago-
cytic lineage, including macrophages, is CSF-1 (Roth and
Stanley, 1992). This dimeric serum growth factor is synthe-
sized in many sites where it is responsible for the local
recruitment of macrophages (Ryan et al., 2001). Consistent
with these observations, studies with mice homozygous for
null mutations in the CSF-1 or its receptor gene have severe
depletion of macrophages in the majority of, but not all,
tissues (Cecchini et al., 1994; Pollard and Stanley, 1996).
This cellular deficiency has many phenotypic consequences
for the mice, including osteopetrosis, impaired neuronal
processing, a perturbed neuroendocrine feedback response,
and immune defects (Pollard and Stanley, 1996). In addi-
tion, the nullizygous mice have impaired branching mor-
phogenesis in the mammary gland, both during develop-
ment and pregnancy (Gouon-Evans et al., 2000). This was
associated with a reduction of macrophages recruited to the
TEB during this outgrowth and to the secondary branches
during pregnancy (Gouon-Evans et al., 2000; Pollard and
Hennighausen, 1994). This suggests that the defects are
related to the local action of macrophages. However, be-
cause of the complex phenotypes of the null mutant mice,
in this study, we wished to test whether this effect was
organ autonomous. Consequently, we reintroduced CSF-1
into the mammary epithelium in a restricted, regulated way
by using the tetracycline-binary system in transgenic mice.
CSF-1 null mutant mice expressing this binary system
showed no corrections of overt phenotypes, including the
osteopetrosis, neuroendocrine defects, and general macro-
phage deficiency, such as that found in the liver and the
mice had no detectable CSF-1 in the serum. Furthermore,
CSF-1 could not be detected in other tissues, except the
salivary and mammary gland, sites where the MMTV-
promoter is known to be active. The MMTV promoter has
also been reported to be expressed in hematopoietic pro-
genitors and, therefore, possibly macrophages (Wagner et
al., 2000). However, since CSF-1 could not be detected in
the macrophage-rich liver and there was no correction of
macrophage populations in tissues other than the mam-
mary gland, this expression, if present, is not sufficient to
restore macrophage populations in Csf1op/Csf1op mice. Even
in the whole mammary gland, the level of CSF-1 was very
low, but since CSF-1 is only expressed in the epithelial
compartment, the local concentration adjacent to the ducts
could be high. Indeed, analysis of macrophage populations
by anti-F4/80 immunostaining revealed restoration of the
density of these cells around the ducts of the mammary
gland but not throughout the mammary gland. In conclu-
sion, local mammary epithelial expression of CSF-1 recruits
macrophages to that site but does not result in any systemic
correction of the macrophage deficiency in Csf1op/Csf1op
mice. This is consistent with experiments where recombi-
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nant soluble CSF-1 was injected into local sites and shown
only to locally recruit macrophages (Wiktor-Jedrzejczak et
al., 1991). The local correction of macrophage populations
in the mammary gland of double-transgenic mice resulted
in accelerated growth of the ductal structure and a more
complex pattern of branching compared to that observed in
single transgenic Csf1op/Csf1op mice. This outgrowth was
also characterized by an ordered ductal structure such that
the invading front was fan-shaped and spread across the fat
pad. This was similar to that observed in wild type mice,
but different from the relative disorganization always found
in Csf1op/Csf1op mice. However, the rate of ductal out-
growth, while much improved in double-transgenic mice,
never reached that of wild type mice.
We also tested whether CSF-1 was continuously required
for ductal development by treating the double-transgenic
Csf1op/Csf1op mice with doxycycline to inhibit CSF-1 ex-
pression. Analysis for CSF-1 mRNA by RT-PCR revealed
that this treatment, while effective, did not completely
suppress CSF-1 expression. Since this binary system was
completely repressed by doxycycline in tissue culture, this
probably reflects the difficulty of achieving high enough
doxycycline concentrations in vivo, especially in pups that
were suckling. Nevertheless, doxycycline treatment
through the first 6 weeks of life reduced the rate of ductal
outgrowth and reduced the branching complexity to that
observed in Csf1op/Csf1op mice containing a single trans-
gene. A similar but less complete inhibitory action was
found in mice treated from the third week of life with
doxycycline. However, in this case, doxycycline treatment
did not reduce the branching complexity compared with
untreated mice. These data suggest that CSF-1-regulated
functions are required continuously during the formation of
the mammary gland.
The accelerated mammary development effected by local
CSF-1 expression is associated with recruitment of macro-
phages to the growing ductal structures. Given that macro-
phages are the only cell in the mammary gland that ex-
presses the CSF-1R (Gouon-Evans et al., 2000), the data
show that CSF-1, through its action on macrophages when
expressed locally, is sufficient to enhance branching mor-
phogenesis and ductal outgrowth and is required through-
out mammary gland development.
Ductal outgrowth requires macrophages to grow out
through the fat pad. This process involves proteolytic
activity and matrix deposition and is associated with exten-
sive angiogenesis. It is regulated by growth factors, many of
which are mesenchymal in origin (Cunha and Hom, 1996;
Daniel and Silberstein, 1987; Sakakura, 1991; Woodward et
al., 1998). Macrophages secrete a number of growth factors,
such as TGF-1 (Letterio and Roberts, 1998), heparin-
binding epidermal growth factor (EGF)-like growth factor
(Higashiyama et al., 1991), platelet-derived growth factor
(PDGF), and interleukin-1 (Lindroos et al., 1997), all of
which may be important in facilitating ductal outgrowth.
For example, TGF-1 is secreted as an inactive form (Nunes
et al., 1997), and this can be activated in the presence of
macrophages (Chong et al., 1999). Activated macrophages
have also been shown to secrete plasmin and
thrombospondin-1 (Yehualaeshet et al., 1999) that can also
activate latent TGF-1. TGF-1 is an important regulator of
branching morphogenesis, both promoting and inhibiting
ductal outgrowth according to concentration (Daniel et al.,
1989; Pollard, 2001). Alternatively, macrophages may be
involved in facilitating TEB’s migration. Interestingly, the
role of macrophages in cell migration has been observed in
other systems (Vincent et al., 1999). Furthermore, there is
evidence showing that macrophages can secrete metallo-
proteases (Ma et al., 1999) and plasminogen activator (uPA)
is a CSF-1-regulated gene in macrophages (Stacey et al.,
1995). These proteases play a role in ductal outgrowth and
morphogenesis (Sympson et al., 1994). Thus, it seems likely
that macrophages produce a combination of factors that are
responsible for the promotion of ductal outgrowth in the
mammary gland. In addition, it has been suggested that
macrophages might be important in the mammary glands
to remove dead cells from the TEBs. Indeed, we have shown
that they engulf apoptotic cell on the inner lumenal surface
of the TEB (Gouon-Evans et al., 2000). In the double-
transgenic Csf1op/Csf1op mice, macrophages were observed
inside the TEBs, a region where apoptotic cells were also
observed (Humphreys, 1999). Thus, macrophages may also
remove apoptotic cells and this process may be a necessary
requirement for ductal outgrowth.
The identification of the sites of CSF-1 synthesis in vivo
have been recently refined by using a -galactosidase recep-
tor gene driven by the CSF-1 promoter, and these studies
have shown that CSF-1 is synthesized in the ductal epithe-
lium and TEB (Ryan et al., 2001). To test whether this
synthesis was necessary for the ductal branching, we trans-
planted mutant mammary epithelial cells unable to synthe-
size CSF-1 into wild type stroma. Unfortunately, it has not
been possible to breed the Csf1op allele onto an inbred
genetic background to perform the reciprocal transfer (it is
currently carried on a mixed background), since it appears
that, in inbred mice, the macrophage deficiencies are more
severe and this results in pre or peri-natal lethality, possibly
because of the absolute requirement for macrophage prod-
ucts for certain processes such as erythropoiesis (Kawane et
al., 2001). Furthermore, macrophages are migratory cells
and grafts will become populated with wild type cells, and
conversely, in mutant mice, since macrophages require
CSF-1 for viability, wild type cells will be lost. However, in
the case of the epithelial transplants to a wild type stroma
and a normal systemic complement of CSF-1 and conse-
quently circulating monocytes, both wild type and mutant
epithelium grew to comparable extents with equivalent
branching complexity. This experiment, together with
those described above when CSF-1 expression was restored
in the mammary epithelium by transgenic means, shows
that, while epithelial CSF-1 expression is sufficient, it is not
necessary for macrophage recruitment and branching mor-
phogenesis. These data suggest that there are other
mammary-derived macrophage chemoattractants other
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than CSF-1, perhaps chemokines such as MIP-1, RANTES,
or C10, the latter two of which we have shown are ex-
pressed in the mammary gland (V. Gouon-Evans and J.W.P.,
unpublished observations). These appear to be sufficient to
recruit macrophages to the growing ductal structure or
other tissues such as the spleen (Baggiolini, 1998), provided
that there are sufficient circulating monocytes. This is
consistent with the partial rescue of the mammary gland
macrophages population and branching complexity by sys-
temic restoration of circulating CSF-1 concentrations that
increases circulating monocytes but which does not provide
local sources of CSF-1 (Gouon-Evans et al., 2000).
In many developmental systems, including the mam-
mary gland, epithelial–mesenchymal interactions are re-
quired for branching morphogenesis. Recently, considerable
progress has been made in delineating the signaling path-
ways involved. For example, during lung and prostate
morphogenesis, roles for BMP and FGF signaling have been
defined (Weaver et al., 2000). In the mammary gland, less is
known about the regulation of branching morphogenesis,
but there is a clear role for wnt signaling in the
progesterone-induced secondary branching (Robinson et al.,
2000). In our studies, we have demonstrated that CSF-1-
regulated macrophages potentiate the estrogen-driven
branching morphogenesis during the establishment of the
ductal tree, as well as during the progesterone-regulated
ductal development during pregnancy (Gouon-Evans et al.,
2000; Pollard and Hennighausen, 1994). These cells provide
trophic cues, such that ductal density is increased and
epithelial outgrowth is enhanced. Macrophages are found
throughout developing tissues and it will be important to
determine whether these actions of macrophages are gen-
eral for all structures that undergo branching morphogen-
esis, such as the lung or pancreas, or are unique to the
mammary gland.
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